Two groups of scientists set out to estimate how much plastic a person takes in. One published a weekly figure with an upper bound of 5 grams. The other published a median daily figure of 583 nanograms for adults. Convert them to the same units and the two estimates sit about a million-fold apart.
Neither group did anything wrong. They counted different size ranges, drew on different source studies, and built on different assumptions, and both said so in print. That gap tells you more about microplastics research right now than any single estimate does, because it shows what kind of question you are asking when you ask whether microplastics are hurting you.
This article runs in three steps, and the steps have to stay apart. Microplastics are measurably present in human tissue. In laboratory systems they do things to cells that nobody wants done to cells. Whether they are harming people at the amounts people encounter is not established. All three statements are true at the same time, and collapsing them into one is how this subject goes wrong in both directions at once.
Step one: the detection is established
Start with what the word covers. The National Oceanic and Atmospheric Administration defines microplastics by size, as plastic pieces under five millimeters, roughly a pencil eraser. Nanoplastics are usually described as under one micron. FDA, which uses those same rough boundaries, notes there are no standard definitions for either category, and offers a scale that helps: a human hair is about 70 microns across.
Two systematic reviews published in 2026 pulled the human detection literature together, and both are worth knowing by their numbers.
A review in Therapeutic Advances in Respiratory Disease searched three databases through June 2025 and included 17 studies. Microplastics are present in human lung tissue, and inhaling airborne particles is a major exposure route, not a side issue.
A review in Reproductive Toxicology searched through September 2025 and included 41 studies. Seven looked at female tissues, nine at male tissues, one at both, and 24 at placental tissue. Microplastics and nanoplastics accumulate in follicular fluid, testis, epididymis, semen and placenta.
FDA’s own page on microplastics in food adds urine, stool, blood and organs, and lists foods where particles have been detected: salt, seafood, sugar, beer, bottled water, honey, milk and tea. Bottled water specifically is covered in another article here, including why the counts in that literature vary so widely.
So detection is not in dispute. What detection means is a separate question, and keeping those apart is the whole discipline of this subject. A chemical or a particle shows up in a tissue sample when somebody develops a method sensitive enough to find it there. That is a statement about instruments as much as about bodies.
Step two: in cells and in animals, they do measurable things
The laboratory evidence is real, consistent and easy to overread.
A 2025 scoping review in the Journal of Hazardous Materials went through the in vitro and in vivo literature and found a recurring set of effects: inflammation, oxidative stress, apoptosis, autophagy and endoplasmic reticulum stress, each through identifiable signaling pathways. In plainer terms, exposed cells show the chemical signature of being under strain, the housekeeping machinery that clears damaged parts gets switched on, and some cells run the self-destruct program that normally removes a cell the body has given up on. Oxidative stress is the imbalance that happens when reactive molecules outpace the antioxidant systems meant to mop them up.
The reproductive review found the same signatures in its studies: activation of oxidative stress pathways, metabolic dysfunction and a shift toward apoptosis.
A 2025 study, also in the Journal of Hazardous Materials, took plastic food containers and counted what came off them. Each container released somewhere between 100,000 and 260,000 particles, with a total extracted mass of 0.1 to 0.3 milligrams. Containers meant for frozen food gave up more, smaller particles than the others. The authors then put those particles on Caco-2 cells, a human intestinal cell line, and watched cell viability fall as the dose rose. More interesting, the subcellular measures moved before the cells died: lysosomes changed in number and size, and reactive oxygen species went up.
Here is the limit on all of it. A cell line in a dish has no liver, no gut lining, no mucus, no immune system and no way to excrete anything. Animals have those, but the exposures given to animals are usually nothing like the ones a person gets. Laboratory effects tell you a material is biologically active. They do not tell you what happens inside a person at the amounts a person encounters.
Step three: the health consequences at real exposures are not established
This is the step that gets cut from headlines, and it is the one the reviewers themselves lead with.
The respiratory review found evidence associating chronic exposure to airborne microplastics with higher risks of chronic obstructive pulmonary disease, asthma and pulmonary fibrosis. Its own conclusion is that definitive causal evidence is constrained. The authors in Therapeutic Advances in Respiratory Disease name the reason without hedging: experimental animal studies use concentrations “vastly exceeding environmental levels,” which limits any extrapolation to real-world risk.
Three specific, nameable problems stand behind that.
The doses are wrong. Animal and cell studies routinely use amounts far above what anyone breathes or eats. The scoping review makes the same complaint in its own words, adding that much of the field relies on manufactured plastic microspheres rather than the weathered, irregular, chemically aged fragments people encounter.
The methods are not comparable. The reproductive review states flatly that preparation and detection methodology varied between the studies it included. When two labs prepare tissue differently and detect particles differently, their counts are not two measurements of the same thing.
The research is lopsided toward one polymer. The respiratory review and the scoping review both say it. Work is disproportionately focused on polystyrene, while the polymers that dominate real exposure and occupational data, such as polyethylene and polypropylene, are understudied.
The consequence shows up in the findings themselves. The reproductive review reports that multiple studies found associations between plastic particle exposure and poor sperm motility, and that findings on ovarian reserve markers and reproductive outcomes were inconsistent. Inconsistent is the honest word, and it is not a synonym for negative.
Regulators have landed in the same place. FDA’s position is that current scientific evidence does not demonstrate that the levels found in foods pose a risk to human health, and that “more research is needed before the agency can assess potential effects of microplastics and nanoplastics on human health.” The World Health Organization reached a similar conclusion for drinking water in 2019, saying microplastics there did not appear to pose a health risk at current levels while stressing that the conclusion rested on extremely limited information. WHO’s assessment also included one mechanistic detail worth holding on to: particles larger than 150 micrometers are not likely to be absorbed by the body at all, and uptake of smaller ones is expected to be limited, with the real uncertainty sitting in the nano range where data are thinnest.
Put in the terms this site uses for evidence, microplastics and human health sit in the insufficient evidence tier. That is a different thing from harmless and a different thing from harmful. It means the studies that would settle it have not been done in the form that would settle it.
Why two frightening numbers cannot be set side by side
Counts are the trap. A particle count depends completely on the smallest particle the instrument can see. Lower the detection limit and the count goes up, with nothing in the sample having changed. Change the digestion chemistry used to free particles from tissue and you change what survives to be counted. Two papers reporting different numbers may not disagree at all.
Both US agencies working on this say so plainly. FDA states there are no standardized methods to detect, quantify or characterize these particles, which leaves many published studies with variable or limited accuracy, and notes that nanoplastic studies are fewer because measurement at that size is not reliable. EPA’s microplastics research page says no single method can characterize the full range of particle sizes, and that standardized collection, extraction, quantification and identification are needed before results can be compared across studies.
Which brings us to the figure everyone has heard.
The credit card. The claim that a person consumes about a credit card’s worth of plastic a week traces to a 2021 analysis in the Journal of Hazardous Materials by a University of Newcastle group, with a co-author from the World Wide Fund for Nature. The researchers pulled data from 59 publications, converted particle counts into an average mass for a single particle in the 0 to 1 millimeter range, applied conservative assumptions, and estimated that people may take in 0.1 to 5 grams of microplastics weekly. Five grams is about the mass of a credit card.
Three things about that are worth knowing. The estimate is a range spanning a factor of 50, and the number in circulation is the very top of it. The paper describes itself as a first attempt at converting counts into a mass figure relevant to human toxicology, not as a measurement of anyone. And it is an estimate of intake, not of what stays in the body.
Set against it, the 2021 probabilistic model in Environmental Science and Technology, which simulated intake from eight food types plus inhalation along with absorption and excretion, put adult median intake at 883 particles a day, or 583 nanograms. That is roughly four micrograms a week, against five million micrograms at the top of the other estimate. The same model found that the contribution of microplastics to people’s total intake of plastic-associated chemicals was small.
The honest reading is not that one paper is right. It is that converting particle counts into a biologically meaningful quantity is an unsolved measurement problem, and the published answers reflect that.
Where they come from, and the routes that matter
NOAA describes two origins: large plastic litter breaking into progressively smaller fragments, and particles manufactured small in the first place, such as microbeads and the resin pellets used in plastic production. FDA says the particles in food come mainly from environmental contamination where food is grown or raised, with air and personal care products as additional routes.
Inhalation deserves more attention than it gets. The respiratory review treats breathing as a key route, and the lifetime exposure model counted inhalation alongside eight food types. Indoor air and settled house dust carry synthetic fibers, and dust as an exposure pathway is covered in its own article here.
Food packaging is where the evidence genuinely conflicts, and it is better to say so than to pick a side. FDA’s page states there is not sufficient evidence that plastic food packaging releases these particles into food or beverages. Recent laboratory work points the other way: besides the container study above, a 2026 paper in Food Chemistry heated microwaveable packaging under conditions meant to mirror ordinary use and detected polyethylene release that rose with heating time, with nanoparticles in the 40 to 240 nanometer range appearing within one to three minutes. Both can be defensible. The agency is describing the weight of evidence across products and polymers; the laboratory studies are recent, specific, and not yet replicated widely enough to support a general statement. This is an open question, not a cover-up, and anyone telling you it is settled in either direction is ahead of the data.
What would have to happen before anyone can answer this
The useful thing about a specific gap is that you can describe what would close it.
Standard methods come first, because nothing else works without them: an agreed way to extract particles from a tissue or a food, an agreed lower size limit, and reporting in both counts and mass so results can be converted. FDA and EPA have both said this in their own words.
Then exposures that resemble real ones: weathered fragments rather than clean microspheres, the polymers people are exposed to rather than polystyrene by default, and doses in the range a person could plausibly receive.
Then time. Most of the animal literature is short. Chronic low-level exposure is the scenario that matters and the one least studied.
Then human studies of the right design. Detecting particles in a tissue sample from people who already have a disease cannot tell you which came first. Answering that requires measuring exposure in individuals and following them, which is slow, expensive and the only route to a dose-response relationship.
A dose-response curve is the thing every practical question depends on. How much is too much has no answer at present, for anyone, because nobody has the curve. After two decades of work, that is not a scientific failure. It is an accurate description of an unusually hard measurement problem, and saying so is more respectful of a reader than a number dressed up as a finding.
What to do in the meantime, and when to involve a clinician
Be clear about what the following is and is not. Nobody can tell you the size of the benefit of any of it, because the dose-response relationship does not exist yet. These are low-cost habits, not protection with a number attached, and none of them requires buying anything.
Heating food in plastic is the one place where the laboratory evidence and ordinary kitchen practice line up, so moving hot food to glass or ceramic before reheating is a reasonable default, and the regulatory side of that is covered in a companion article on food-contact materials. Ventilation and ordinary dust control reduce what is in indoor air. Conventional water treatment already removes most particles: WHO reported that wastewater treatment can take out over 90 percent, with filtration performing best.
What does not earn its keep: replacing a functioning kitchen, or paying attention to any product marketed as microplastic-free, which is an undefined claim with no test behind it. There is no detox for this and nothing to buy.
On the medical side, two things are worth knowing. There is no clinical test for how much plastic is in your body, so there is no result to act on and no clinician who can give you one. And the symptoms people attribute to microplastics almost always have causes that can be diagnosed and treated. A cough that persists for weeks, new breathlessness on exertion, or wheeze deserves a clinical evaluation on its own merits, and matters more if you have worked in textiles, flocking, plastics manufacturing or recycling, where occupational exposure is documented and respiratory assessment is standard. If you are worried about fertility, an evaluation is useful precisely because the measurable causes are the treatable ones. In pregnancy, raise it with your clinician rather than changing anything on your own.
The habit worth keeping
When you next see a microplastics number, ask four questions of it: what was counted, down to what size, in what tissue or food, and by what method. Three of the four are usually missing from the headline, and the number means very little without them.
Hold detection and harm apart in your head. They are both real subjects. They are not the same subject, and the day someone links them properly will be a day with a dose-response curve in it.
Sources
- U.S. Food and Drug Administration. “Microplastics and Nanoplastics in Foods.” fda.gov
- U.S. Environmental Protection Agency. “Microplastics Research.” epa.gov
- National Oceanic and Atmospheric Administration, National Ocean Service. “What are microplastics?.” oceanservice.noaa.gov
- World Health Organization. “WHO calls for more research into microplastics and a crackdown on plastic pollution.” who.int
- PubMed. “Chen C, Luo L, Zheng Y, et al. "Evidence on microplastic exposure and respiratory health outcomes: a systematic review." Therapeutic Advances in Respiratory Disease, 2026. DOI: 10.1177/17534666261465486.” doi.org
- PubMed. “Patel NK, Rhoton-Vlasak A, Jung S, Schaub AM. "Plastics in Human Reproductive Tissues: A Systematic Review of Detection, Characterization, and Effects on Fertility." Reproductive Toxicology, 2026. DOI: 10.1016/j.reprotox.2026.109384.” doi.org
- PubMed. “Bridgeman L, Cimbalo A, Lopez-Rodriguez D, Pamies D, Frangiamone M. "Exploring toxicological pathways of microplastics and nanoplastics: Insights from animal and cellular models." Journal of Hazardous Materials, 2025. DOI: 10.1016/j.jhazmat.2025.137795.” doi.org
- PubMed. “Senathirajah K, Attwood S, Bhagwat G, et al. "Estimation of the mass of microplastics ingested, a pivotal first step towards human health risk assessment." Journal of Hazardous Materials, 2021. DOI: 10.1016/j.jhazmat.2020.124004.” doi.org
- PubMed. “Mohamed Nor NH, Kooi M, Diepens NJ, Koelmans AA. "Lifetime Accumulation of Microplastic in Children and Adults." Environmental Science and Technology, 2021. DOI: 10.1021/acs.est.0c07384.” doi.org
- PubMed. “Xia Y, Wang WX. "Subcellular toxicity assessments of microplastics released from food containers." Journal of Hazardous Materials, 2025. DOI: 10.1016/j.jhazmat.2025.137541.” doi.org
- PubMed. “Lin PY, Hsieh SL, Wu IH, Hsieh YC, Hsieh S. "Invisible plastic release from overlooked usage practices in microwaved food packaging." Food Chemistry, 2026. DOI: 10.1016/j.foodchem.2026.149912.” doi.org